Trial Profile
To evaluate the effects of citalopram, paroxetine and sertraline in adults with depression with suicidal ideation.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jul 2023
Price :
$35
*
At a glance
- Drugs Citalopram (Primary) ; Paroxetine (Primary) ; Sertraline (Primary)
- Indications Depression; Suicidal ideation
- Focus Therapeutic Use
- 16 Feb 2018 New trial record
- 05 Feb 2018 Results published in the British Journal of Psychiatry